Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5

Circulation Research · Published 2026-08-04 · DOI 10.1161/circresaha.126.328827

Free full text

Authors (10)

Laura Lalaguna, Marina López-Olañeta, Carlos Torroja, Carlos Relaño-Rupérez, Carlos Fernández-Sellers, Fátima Sánchez-Cabo, Juan Pablo Ochoa, Esther Zorio, Pablo García-Pavía, Enrique Lara-Pezzi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lalaguna, L., López-Olañeta, M., Torroja, C., et al. (2026). Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5. Circulation Research. https://doi.org/10.1161/circresaha.126.328827

Related articles

• Small Extracellular Vesicles From Cardiomyocytes Activate Microglia Aggravating HFpEF · Circulation Research · 2026 · Same journal
• Contractility Drives Cardiomyocyte Maturation and the Response to Nanopatterns · Circulation Research · 2026 · Same journal
• Monocyte Dll4 Contributes to Systemic Inflammation in People Living With HIV · Circulation Research · 2026 · Same journal
• Lipoproteins in Cardiovascular Disease: Building on Successes to Meet Future Challenges · Circulation Research · 2026 · Same journal
• Epicardial Fat Drives Macrophage Response in Atrial Cardiomyopathy · Circulation Research · 2026 · Same journal
• Inflammasome-Primed Neutrophils Aggravate Atherosclerosis in Cigarette Smoking · Circulation Research · 2026 · Same journal
• Antibody E06 and the Role of Oxidized Phospholipids in Atherogenesis and Inflammation · Circulation Research · 2026 · Same journal
• Glycine Receptor α2 Mediates Vasodilation via Endothelial eNOS Signaling · Circulation Research · 2026 · Same journal
• Distinct Urinary Protein Signatures in Adolescent Blood Pressure Phenotypes · Circulation Research · 2026 · Same journal
• Kidney-Vascular Metabolic Crosstalk: Altered Lipoproteins in CKD · Circulation Research · 2026 · Same journal